Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4269206)

Published in Clin Res Cardiol on March 09, 2013

Authors

Ulrike Theidel1, Christian Asseburg, Evangelos Giannitsis, Hugo Katus

Author Affiliations

1: Herescon Gmbh, Königsworther Str. 2 30167 Hannover, Germany. theidel@herescon.com [corrected]

Associated clinical trials:

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome (PLATO) | NCT00391872

Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation (REACTIC-TAVI) | NCT04331145

Articles cited by this

Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03

Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85

Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78

Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study. Eur Heart J (2012) 2.16

Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke (2006) 1.90

A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes (2010) 1.83

[Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations]. Z Kardiol (2004) 1.56

Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation (2011) 1.33

Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur Heart J (2008) 1.16

[Guidelines: Acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation]. Z Kardiol (2004) 1.06

Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability. Value Health (2005) 1.05

Medical resource use and costs of health care after acute stroke in Germany. Eur J Neurol (2005) 1.01

Impact of anticoagulation before stroke on stroke severity and long-term survival. Int J Stroke (2011) 0.95

Acute coronary syndromes in Europe: 1-year costs and outcomes. Curr Med Res Opin (2007) 0.93

A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. Pharmacoeconomics (2006) 0.90

[Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases]. Herz (2008) 0.89

Mortality in a cardiac intensive care unit. Clin Res Cardiol (2012) 0.88

[Long-term disease-related costs 4 years after stroke or TIA in Germany]. Nervenarzt (2008) 0.83

GRACE risk score as predictor of in-hospital mortality in patients with chest pain. Clin Res Cardiol (2010) 0.81

[Costs caused by bleeds within the therapy of acute coronary syndromes in Germany]. Herz (2009) 0.81

The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk. Can J Cardiol (2007) 0.81

Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes. Curr Med Res Opin (2005) 0.81

Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany. Curr Med Res Opin (2008) 0.80

[Not Available]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2002) 0.79

Articles by these authors

Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03

OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation (2010) 4.60

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Lancet (2010) 3.55

New insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencing. Nat Commun (2012) 3.18

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet (2010) 2.98

Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA (2011) 2.61

Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet (2008) 2.26

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J (2009) 2.23

Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem (2011) 2.14

Interpreting changes in troponin--clinical judgment is essential. Clin Chem (2012) 2.06

Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol (2012) 2.02

How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J (2012) 2.00

Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation (2010) 1.96

Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nat Methods (2005) 1.93

Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J (2010) 1.88

Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart (2010) 1.87

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol (2012) 1.84

Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol (2010) 1.78

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation (2013) 1.77

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ (2011) 1.74

High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension. Clin Sci (Lond) (2010) 1.70

Prevalence of different gadolinium enhancement patterns in patients after heart transplantation. J Am Coll Cardiol (2008) 1.63

Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ (2007) 1.54

Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in Death Valley. Clin Res Cardiol (2007) 1.54

Strain-encoded cardiac magnetic resonance during high-dose dobutamine stress testing for the estimation of cardiac outcomes: comparison to clinical parameters and conventional wall motion readings. J Am Coll Cardiol (2011) 1.53

Cardiac troponin elevations in patients without acute coronary syndrome. Circulation (2002) 1.53

Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes). JACC Cardiovasc Interv (2013) 1.46

Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project. Heart (2009) 1.46

Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes. Thromb Haemost (2008) 1.44

The German CPU Registry: comparison of troponin positive to troponin negative patients. Int J Cardiol (2013) 1.43

Early assessment of infarct size and prediction of functional recovery by quantitative myocardial blush grade in patients with acute coronary syndromes treated according to current guidelines. Catheter Cardiovasc Interv (2010) 1.43

Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart (2010) 1.43

Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42

The Use of Echocardiography in Certified Chest Pain Units: Results from the German Chest Pain Unit Registry. Cardiology (2016) 1.41

Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction. Crit Care Med (2002) 1.41

Differential diagnosis of elevated troponins. Heart (2006) 1.40

Acute phase reaction to gadolinium-DTPA in dialysis patients. Nephrol Dial Transplant (2008) 1.39

Mirror, mirror on the wall: the quest for the earliest marker of myocardial ischaemia. Eur Heart J (2005) 1.38

The functional response of a generalist predator. PLoS One (2010) 1.34

Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia. Clin Chem (2008) 1.32

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation (2010) 1.30

Systemic first-line phenotyping. Methods Mol Biol (2009) 1.26

Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol (2006) 1.16

Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail (2008) 1.14

ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy. Circulation (2011) 1.13

Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J (2010) 1.11

Innovations in phenotyping of mouse models in the German Mouse Clinic. Mamm Genome (2012) 1.09

Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol (2010) 1.08

Strain-encoded CMR for the detection of inducible ischemia during intermediate stress. JACC Cardiovasc Imaging (2010) 1.07

Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography. Eur Radiol (2010) 1.06

Recurrence of takotsubo cardiomyopathy with variant forms of left ventricular dysfunction. J Am Soc Echocardiogr (2007) 1.04

Image quality and radiation dose in 256-slice cardiac computed tomography: comparison of prospective versus retrospective image acquisition protocols. Eur J Radiol (2010) 1.04

Anomalous origin of the left circumflex coronary artery from the pulmonary artery. A very rare congenital anomaly in an adult patient diagnosed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2008) 1.04

Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem (2004) 1.03

Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. Clin Chem (2009) 1.03

Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am Heart J (2012) 1.03

Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study. Cardiovasc Drugs Ther (2006) 1.01

Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome. Atherosclerosis (2010) 1.01

Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study. Clin Res Cardiol (2015) 1.00

Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway. Mediators Inflamm (2010) 0.99

Reduction of radiation exposure and improvement of image quality with BMI-adapted prospective cardiac computed tomography and iterative reconstruction. Eur J Radiol (2011) 0.99

Sensitivity to assumptions in models of generalist predation on a cyclic prey. Ecology (2007) 0.99

Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem (2002) 0.98

Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia? J Public Health (Oxf) (2010) 0.97

Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography. J Cardiovasc Magn Reson (2009) 0.97

The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J (2014) 0.97

Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2006) 0.97

Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE. J Mol Med (Berl) (2006) 0.96

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J (2012) 0.96

Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes (2012) 0.96

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood (2010) 0.95

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. Acta Oncol (2011) 0.95

Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the "German chest pain unit registry". Clin Res Cardiol (2012) 0.95

Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome. Clin Chem (2012) 0.94

The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy. J Am Coll Cardiol (2011) 0.94

Strain-encoded (SENC) magnetic resonance imaging to evaluate regional heterogeneity of myocardial strain in healthy volunteers: Comparison with conventional tagging. J Magn Reson Imaging (2009) 0.93

Impact of systolic and diastolic deformation indexes assessed by strain-encoded imaging to predict persistent severe myocardial dysfunction in patients after acute myocardial infarction at follow-up. J Am Coll Cardiol (2010) 0.93

Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data. BMJ Open (2014) 0.92

Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J (2008) 0.92

Strain-encoded cardiac MR during high-dose dobutamine stress testing: comparison to cine imaging and to myocardial tagging. J Magn Reson Imaging (2009) 0.92

Single coronary artery with anomalous rising of the right coronary artery: a rare coronary anomaly diagnosed by 256-multidetector computed tomography. Case Rep Med (2011) 0.92

Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis. Heart (2007) 0.92

Visualization of a coronary fistula with pulmonary drainage. Clin Res Cardiol (2006) 0.91

Classification of diastolic function with phase-contrast cardiac magnetic resonance imaging: validation with echocardiography and age-related reference values. Clin Res Cardiol (2014) 0.91

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study. Clin Chem (2011) 0.90

Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor. Clin Chem (2006) 0.90

Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem (2007) 0.90

Aquaporin-1 channel function is positively regulated by protein kinase C. J Biol Chem (2007) 0.89

High-sensitive Troponin T measurements early after heart transplantation predict short- and long-term survival. Transpl Int (2012) 0.89

Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur Heart J (2008) 0.89

Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem (2011) 0.89

Strain-encoded MRI for evaluation of left ventricular function and transmurality in acute myocardial infarction. Circ Cardiovasc Imaging (2009) 0.89

A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88

Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene. Int J Cardiol (2008) 0.88

Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging. Clin Res Cardiol (2009) 0.87